{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:50:29Z","timestamp":1726851029634},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,29]]},"DOI":"10.7759\/cureus.19128","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T18:00:31Z","timestamp":1635530431000},"source":"Crossref","is-referenced-by-count":1,"title":["Tumor Lysis Syndrome in Patients With Hepatocellular Carcinoma: A Systematic Review of Published Case Reports
"],"prefix":"10.7759","author":[{"given":"Jen-Wei","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trupti","family":"Akella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teressa","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2014.5389","article-title":"Tumor lysis syndrome in solid tumors: an up to date review of the literature","volume":"6","author":"Mirrakhimov AE","year":"2014","unstructured":"Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014, 6:5389. 10.4081\/rt.2014.5389","journal-title":"Rare Tumors"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher D","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al.. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015, 4:1. 10.1186\/2046-4053-4-1","journal-title":"Syst Rev"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1097\/00007611-199805000-00012","article-title":"Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma","volume":"91","author":"Burney IA","year":"1998","unstructured":"Burney IA. Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J. 1998, 91:467-70.","journal-title":"South Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200301000-00008","article-title":"Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?","volume":"325","author":"Vaisban E","year":"2003","unstructured":"Vaisban E, Braester A, Mosenzon O, Kolin M, Horn Y. Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?. Am J Med Sci. 2003, 325:38-40. 10.1097\/00000441-200301000-00008","journal-title":"Am J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.04.1265","article-title":"Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma","volume":"185","author":"Lehner SG","year":"2005","unstructured":"Lehner SG, Gould JE, Saad WE, Brown DB. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol. 2005, 185:1307-9. 10.2214\/AJR.04.1265","journal-title":"AJR Am J Roentgenol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-1-87","article-title":"Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma","volume":"11","author":"Lee CC","year":"2006","unstructured":"Lee CC, Wu YH, Chung SH, Chen WJ. Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma. Oncologist. 2006, 11:87-9. 10.1634\/theoncologist.11-1-87","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-005-0240-8","article-title":"Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma","volume":"30","author":"Sakamoto N","year":"2007","unstructured":"Sakamoto N, Monzawa S, Nagano H, Nishizaki H, Arai Y, Sugimura K. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2007, 30:508-11. 10.1007\/s00270-005-0240-8","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00958.x","article-title":"Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma","volume":"99","author":"Shiba H","year":"2008","unstructured":"Shiba H, Ishida Y, Wakiyama S, Sakamoto T, Misawa T, Yanaga K. Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma. Cancer Sci. 2008, 99:2104-5. 10.1111\/j.1349-7006.2008.00958.x","journal-title":"Cancer Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4464","article-title":"Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient","volume":"15","author":"Huang WS","year":"2009","unstructured":"Huang WS, Yang CH. Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient. World J Gastroenterol. 2009, 15:4464-6. 10.3748\/wjg.15.4464","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4726","article-title":"Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review","volume":"15","author":"Hsieh PM","year":"2009","unstructured":"Hsieh PM, Hung KC, Chen YS. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review. World J Gastroenterol. 2009, 15:4726-8. 10.3748\/wjg.15.4726","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3153","article-title":"A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome","volume":"49","author":"Joshita S","year":"2010","unstructured":"Joshita S, Yoshizawa K, Sano K, et al.. A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med. 2010, 49:991-4. 10.2169\/internalmedicine.49.3153","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000319695","article-title":"Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features","volume":"33","author":"Wang K","year":"2010","unstructured":"Wang K, Chen Z. Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features. Onkologie. 2010, 33:532-5. 10.1159\/000319695","journal-title":"Onkologie"},{"key":"ref15","article-title":"Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report","volume":"57","author":"Shiozawa K","year":"2010","unstructured":"Shiozawa K, Watanabe M, Takenaka H, Nagai H, Ishii K, Sakai K, Sumino Y. Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report. Hepatogastroenterology. 2010, 57:688-90.","journal-title":"Hepatogastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4858","article-title":"All that glitters: sorafenib","volume":"50","author":"Abbass K","year":"2011","unstructured":"Abbass K, Dewani S, Markert R, Kaplon MK, Baumann MA. All that glitters: sorafenib. Intern Med. 2011, 50:797. 10.2169\/internalmedicine.50.4858","journal-title":"Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000339083","article-title":"Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report","volume":"21","author":"Chao CT","year":"2012","unstructured":"Chao CT, Chiang CK. Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report. Med Princ Pract. 2012, 21:498-500. 10.1159\/000339083","journal-title":"Med Princ Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.111251","article-title":"Spontaneous tumour lysis syndrome","volume":"184","author":"Kekre N","year":"2012","unstructured":"Kekre N, Djordjevic B, Touchie C. Spontaneous tumour lysis syndrome. CMAJ. 2012, 184:913-6. 10.1503\/cmaj.111251","journal-title":"CMAJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-012-9373-6","article-title":"Tumour lysis syndrome: a rare complication of trans-arterial chemo-embolisation with doxorubicin beads for hepatocellular carcinoma","volume":"43","author":"Katiman D","year":"2012","unstructured":"Katiman D, Manikam J, Goh KL, Abdullah BJ, Mahadeva S. Tumour lysis syndrome: a rare complication of trans-arterial chemo-embolisation with doxorubicin beads for hepatocellular carcinoma. J Gastrointest Cancer. 2012, 43:S187-90. 10.1007\/s12029-012-9373-6","journal-title":"J Gastrointest Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2011.12.009","article-title":"Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma","volume":"111","author":"Tsai WL","year":"2012","unstructured":"Tsai WL, Liang PC, Chen CH. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma. J Formos Med Assoc. 2012, 111:724-5. 10.1016\/j.jfma.2011.12.009","journal-title":"J Formos Med Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.11405\/nisshoshi.110.441","article-title":"A case of hepatocellular carcinoma with tumor lysis syndrome after transcatheter hepatic artery embolization [Article in Japanese]","volume":"110","author":"Nishida Y","year":"2013","unstructured":"Nishida Y, Fujii H, Hagihara J, et al.. A case of hepatocellular carcinoma with tumor lysis syndrome after transcatheter hepatic artery embolization [Article in Japanese]. Nihon Shokakibyo Gakkai Zasshi. 2013, 110:441-8. 10.11405\/nisshoshi.110.441","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4021\/jmc1049w","article-title":"Fatal tumor lysis syndrome following sorafenib treatment","volume":"4","author":"Habib G","year":"2013","unstructured":"Habib G, Nashashibi M. Fatal tumor lysis syndrome following sorafenib treatment. J Med Cases. 2013, 4:269-270. 10.4021\/jmc1049w","journal-title":"J Med Cases"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000360362","article-title":"Spontaneous tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma","volume":"23","author":"Mehrzad R","year":"2014","unstructured":"Mehrzad R, Saito H, Krahn Z, Feinstein A. Spontaneous tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma. Med Princ Pract. 2014, 23:574-6. 10.1159\/000360362","journal-title":"Med Princ Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-014-0186-2","article-title":"Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma","volume":"4","author":"Kudo C","year":"2015","unstructured":"Kudo C, Miura M, Gamoh M, et al.. Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma. Int Cancer Conf J. 2015, 4:147-50. 10.1007\/s13691-014-0186-2","journal-title":"Int Cancer Conf J"},{"key":"ref25","article-title":"Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma","volume":"32","author":"Kim SY","year":"2015","unstructured":"Kim SY, Kim HY, Kim YS, Lee SM, Kim CW. Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma. Yeungnam Univ J Med. 2015, 32:47-9.","journal-title":"Yeungnam Univ J Med"},{"key":"ref26","article-title":"Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient","volume":"21","author":"Kim JO","year":"2015","unstructured":"Kim JO, Jun DW, Tae HJ, et al.. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient. Clin Mol Hepatol. 2015, 21:85-8.","journal-title":"Clin Mol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.04.019","article-title":"Tumor lysis syndrome: a serious complication of transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"129","author":"Jiang RD","year":"2016","unstructured":"Jiang RD, Jian WC, Jin N, Zhang ZL, Li T. Tumor lysis syndrome: a serious complication of transcatheter arterial chemoembolization for hepatocellular carcinoma. Am J Med. 2016, 129:e173-6. 10.1016\/j.amjmed.2016.04.019","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.09.003","article-title":"Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: an unusual case and systematic literature review","volume":"41","author":"Agarwala R","year":"2017","unstructured":"Agarwala R, Batta A, Suryadevera V, Kumar V, Sharma V, Rana SS. Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: an unusual case and systematic literature review. Clin Res Hepatol Gastroenterol. 2017, 41:e29-31. 10.1016\/j.clinre.2016.09.003","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2018.03.004","article-title":"Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma","volume":"13","author":"Imam SZ","year":"2020","unstructured":"Imam SZ, Zahid MF, Maqbool MA. Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma. Hematol Oncol Stem Cell Ther. 2020, 13:168-70. 10.1016\/j.hemonc.2018.03.004","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref30","article-title":"Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease","volume":"21","author":"An C","year":"2015","unstructured":"An C, Choi YA, Choi D, et al.. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. Clin Mol Hepatol. 2015, 21:279-86.","journal-title":"Clin Mol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tree.2013.05.020","article-title":"Tumor growth dynamics: insights into evolutionary processes","volume":"28","author":"Rodriguez-Brenes IA","year":"2013","unstructured":"Rodriguez-Brenes IA, Komarova NL, Wodarz D. Tumor growth dynamics: insights into evolutionary processes. Trends Ecol Evol. 2013, 28:597-604. 10.1016\/j.tree.2013.05.020","journal-title":"Trends Ecol Evol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.2937","article-title":"Spontaneous complete necrosis of hepatocellular carcinoma: a case report and review of the literature","volume":"9","author":"Takeda Y","year":"2015","unstructured":"Takeda Y, Wakui N, Asai Y, et al.. Spontaneous complete necrosis of hepatocellular carcinoma: a case report and review of the literature. Oncol Lett. 2015, 9:1520-6. 10.3892\/ol.2015.2937","journal-title":"Oncol Lett"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao G","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008, 48:2064-77. 10.1002\/hep.22605","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13403","article-title":"Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology","volume":"169","author":"Jones GL","year":"2015","unstructured":"Jones GL, Will A, Jackson GH, Webb NJ, Rule S. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2015, 169:661-71. 10.1111\/bjh.13403","journal-title":"Br J Haematol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv317","article-title":"FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk","volume":"26","author":"Spina M","year":"2015","unstructured":"Spina M, Nagy Z, Ribera JM, et al.. FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Ann Oncol. 2015, 26:2155-61. 10.1093\/annonc\/mdv317","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402235","article-title":"Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial","volume":"15","author":"Pui CH","year":"2001","unstructured":"Pui CH, Jeha S, Irwin D, Camitta B. Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia. 2001, 15:1505-9. 10.1038\/sj.leu.2402235","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/14249-tumor-lysis-syndrome-in-patients-with-hepatocellular-carcinoma-a-systematic-review-of-published-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:29Z","timestamp":1707507149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/14249-tumor-lysis-syndrome-in-patients-with-hepatocellular-carcinoma-a-systematic-review-of-published-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.19128","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,29]]}}}